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It is generally accepted that extracellular Ca 2ϩ influx plays a critical role in growth factor-induced cell proliferation (18) . Moreover, extracellular Ca 2ϩ influx via nonselective cation channels (NSCCs) is important for the growth factor-induced mitogenic response in mouse fibroblasts (12) . However, it remains unclear whether Ca 2ϩ influx is essential for ET-1-induced mitogenesis of native vascular smooth muscle cells (VSMCs), and it is equally unclear what types of Ca 2ϩ channels are involved in mitogenesis in native VSMCs. These uncertainties are mainly attributable to the lack of specific Ca 2ϩ channel blockers. Therefore, we attempted to pharmacologically characterize the Ca 2ϩ channels activated by ET-1 in internal carotid artery (ICA) VSMCs using the Ca 2ϩ channel blockers SK&F-96365 and LOE-908 (4, 14) . ET-1 binds to its receptors and induces a biphasic increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) consisting of a transient peak and a subsequent sustained increase (11, 15) . It is generally accepted that the sustained increase in [Ca 2ϩ ] i requires the persistent entry of extracellular Ca 2ϩ , whereas the transient increase results from mobilization of Ca 2ϩ from the intracellular Ca 2ϩ store (6). We recently showed (11) that the ET-1-induced sustained increase in [Ca 2ϩ ] i within A7r5 cells, which are cultured thoracic aorta VSMCs that predominantly express ET A Rs, is the result of Ca 2ϩ influx through voltage-independent Ca 2ϩ channels (VICCs) in addition to voltage-operated Ca 2ϩ channels (VOCCs). These VICCs (associated with ET A Rs) consist of two types of Ca 2ϩ -permeable NSCCs (designated NSCC-1 and NSCC-2) and one store-operated Ca 2ϩ channel (SOCC) (11) . In particular, we demonstrated that these channels can be discriminated by using SK&F-96365 and LOE-908. That is, NSCC-1 is sensitive to LOE-908 and resistant to SK&F-96365, NSCC-2 is sensitive to both LOE-908 and SK&F-96365, and SOCC is resistant to LOE-908 and sensitive to SK&F-96365 (11) . Thus SK&F-96365 and LOE-908 may be useful to identify which Ca 2ϩ channels are activated by ET-1 and which Ca 2ϩ channels are involved in ET-1-induced mitogenesis in ICA VSMCs.
MATERIALS AND METHODS
Preparation and primary culture of ICA VSMCs for whole cell recording and monitoring of [Ca 2ϩ ]i. Isolated VSMCs were prepared from rabbit ICA as described previously (5, 10, 15) . Briefly, male Japanese White rabbits, each weighing 2-3 kg, were anesthetized by an intravenous injection of thiopental sodium (20 mg/kg) and killed by exsanguination. The ICA was removed, cleaned of surrounding tissues, dissected into small strips (2 mm ϫ 5 mm), and kept in Ca 2ϩ -free Krebs-HEPES solution containing (in mM) 140 NaCl, 3 KCl, 1 MgCl 2, 11 glucose, and 10 HEPES (pH 7.3, adjusted with NaOH). The strips were incubated overnight (12-24 h) at 4°C in Ca 2ϩ -free Krebs-HEPES solution containing papain (0.2-0.3 mg/ml) and 0.5 mM dithiothreitol. Thereafter, the strips were resuspended and incubated in Ca 2ϩ -free Krebs-HEPES solution containing collagenase (0.25-0.5 mg/ml) at 35°C for 10 min. The digested strips were cut into pieces with fine scissors and triturated with a blunt-tipped pipette until a sufficient number of single cells were released. The freshly dispersed cells were used for electrophysiological experiments. For measurement of [Ca 2ϩ ]i, dispersed VSMCs were seeded on 60-mm tissue culture dishes (Falcon) and cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS supplemented with 100 U/ml penicillin G and 100 g/ml streptomycin at 37°C in a humidified 5% CO 2-95% air atmosphere.
Electrophysiology and measurement of [Ca 2ϩ ]i. Whole cell recordings and measurement of [Ca 2ϩ ]i were performed as previously described (5, 11 3 H]thymidine incorporation were performed as described previously (17) .
Statistical analysis. Results are expressed as means Ϯ SE. Data were subjected to a two-way analysis of variance. When a significant F-value was encountered, the Newman-Keuls multiple-range test was used to test for significant differences between treatment groups. A probability level of P Ͻ 0.05 was considered statistically significant.
Drugs. Boehringer Ingelheim (Ingelheim, Germany) kindly provided LOE-908. Other reagents were commercially obtained from the following sources: ET-1 from Peptide Institute (Osaka, Japan), SK&F-96365 from Biomol (Plymouth Meeting, PA), fluo 3-AM from Dojindo Laboratories (Kumamoto, Japan), nifedipine and MTT from Sigma (St. Louis, MO), and [ 3 H]thymidine from NEN (Boston, MA).
RESULTS

Effects of ET-1 on VOCC activation.
We first attempted to determine the maximal concentration of nifedipine for complete inhibition of the L-type VOCC. We tested the effects of various concentrations of nifedipine on an increase in [Ca 2ϩ ] i induced by high-K ϩ (50 mM) stimulation, which causes depolarization of the plasma membrane and subsequent activation of the VOCC. Nifedipine completely inhibited the high K ϩ -induced increase in [Ca 2ϩ ] i at concentrations Ն1 M (data not shown). Thus, in the following experiments, we added 1 M nifedipine to the bath solution to block the VOCC completely.
ET-1 at 10 nM induced a biphasic increase in [Ca 2ϩ ] i consisting of an initial transient peak and a subsequent sustained phase (Fig. 1A) . On the other hand, 0.1 nM ET-1 evoked only a sustained increase in [Ca 2ϩ ] i (Fig. 1C) . After removal of extracellular Ca 2ϩ , the transient peak was unaffected but the sustained increase evoked by 10 nM ET-1 was abolished (data not shown), indicating that only a sustained increase results from Ca 2ϩ influx. Nifedipine suppressed the 10 nM ET-1-induced sustained increase in [Ca 2ϩ ] i by a maximum of no more than 10% at concentrations Ն1 M (Fig. 1B) . In contrast, the 0.1 nM ET-1-induced sustained increase in [Ca 2ϩ ] i was not affected by nifedipine up to 1 M (Fig. 1D) .
Characterization of currents induced by ET-1 in ICA VSMCs with whole cell recordings by patch clamp. In the presence of 1 M nifedipine, 10 nM ET-1 induced inward currents in ICA VSMCs held at Ϫ60 mV ( Fig.  2A) . Currents induced by ET-1 showed linear currentvoltage relationships with reversal potentials of Ϫ5.4 Ϯ 1.2 mV (n ϭ 10; Fig. 2B ). Current-voltage relationships induced by ET-1 were not affected by the reduction of the Cl Ϫ concentration in the bath solution from 149 mM to 9 mM (data not shown). The reversal potential was Ϫ3.6 Ϯ 1.4 mV (n ϭ 10). To test whether channels activated by ET-1 were permeable to Ca 2ϩ , all monovalent cations in the bath solution were replaced with nonpermeant cation N-methyl-D-glucamine (NMDG) while the concentration of Ca 2ϩ was elevated from 1 mM to 30 mM. Even under such conditions, ET-1 induced inward currents in ICA VSMCs held at Ϫ60 mV (Fig. 2C) . The reversal potential was Ϫ10.3 Ϯ 1.6 mV (n ϭ 10; Fig. 2D ).
Pharmacological properties of whole cell currents induced by ET-1 in ICA VSMCs. To determine the maximally effective concentration of Ca 2ϩ channel blockers such as SK&F-96365 or LOE-908, we first examined the effects of various concentrations (ϳ30 nM-30 M) of these blockers on whole cell currents in ICA VSMCs induced by ET-1. SK&F-96365 and LOE-908 inhibited ET-1-induced currents in a concentration-dependent manner with IC 50 values of 2.1 Ϯ 0.3 and 1.9 Ϯ 0.3 M, respectively, and maximal inhibition was observed at concentrations Ն10 M (data not shown). On the basis of these data, we used 10 M as the maximally effective concentration of SK&F-96365 and LOE-908 in the following experiments.
ET-1-induced currents were abolished by 10 M LOE-908 (Fig. 3A) , and a major portion (ϳ65%) of these currents were suppressed by 10 M SK&F-96365 (Fig.  3C) . The characteristics of the currents inhibited by LOE-908 or SK&F-96365 were essentially similar to those of ET-1-induced currents in terms of linear current-voltage relationships and reversal potentials of approximately Ϫ2 to Ϫ5 mV (Fig. 3, B and D) . ET-1 failed to induce currents in ICA VSMCs pretreated with 10 M LOE-908, whereas ET-1 induced currents in ICA VSMCs preincubated with 10 M SK&F-96365 (data not shown). The magnitude of the current in SK&F-96365-treated ICA VSMCs was ϳ35% of that in nontreated ICA VSMCs. SK&F-96365 in a concentration-dependent manner, with an IC 50 value of 2.7 Ϯ 0.4 M, and abolished at concentrations Ն10 M (Fig. 4A) . However, the increase in [Ca 2ϩ ] i was not affected by LOE-908 up to a concentration of 30 M (Fig. 4B) .
Pharmacological analysis of ET-1-induced increase in [Ca 2ϩ ] i . The sustained increase in [Ca 2ϩ ] i evoked by 10 nM ET-1 was suppressed by LOE-908 in a concentration-dependent manner, and maximal inhibition was observed at concentrations Ն10 M (Fig. 5A) . The extent of maximal inhibition was ϳ60%. On the other hand, the sustained increase in [Ca 2ϩ ] i was suppressed by SK&F-96365 in a concentration-dependent manner, and maximal inhibition was observed at concentrations Ն10 M (Fig. 5B) . The extent of maximal inhibition was ϳ80%. The sustained increase in [Ca 2ϩ ] i caused by 0.1 nM ET-1 was abolished by 10 M LOE-908 (Fig. 5C ), whereas it was not affected by 10 M SK&F-96365 (Fig. 5D) .
ET-1 induced a transient increase in [Ca 2ϩ ] i in a concentration-dependent manner with EC 50 values of ϳ2 nM in ICA VSMCs treated with or without 10 M LOE-908 or 10 M SK&F-96365 before stimulation with ET-1 (Fig. 6A) . ET-1 also induced a sustained increase in [Ca 2ϩ ] i in these cells. However, the EC 50 values of ET-1 differed between these cells. In ICA VSMCs, the EC 50 values of ET-1 were 0.6 Ϯ 0.3 nM and the maximal effect was observed at concentrations Ն10 nM (Fig. 6B) . In ICA VSMCs treated with LOE-908 before stimulation with ET-1, the EC 50 values were within 0.1 nM and the maximal effect was observed at concentrations Ն0.1 nM (Fig. 6B) . In ICA VSMCs treated with SK&F-96365 before stimulation with ET-1, the EC 50 values were 2.7 Ϯ 0.3 nM and the maximal effect was observed at concentrations Ն10 nM (Fig. 6B) .
LOE-908 and SK&F-96365 inhibited the 10 nM ET-1-induced sustained increase in [Ca 2ϩ ] i in a concentration-dependent manner, with IC 50 values of 2.6 Ϯ 0.2 and 2.3 Ϯ 0.3 M, respectively, and maximal inhibition was observed at concentrations Ն10 M (Fig. 6C) . The extent of maximal inhibition of the sustained increase in [Ca 2ϩ ] i in ICA VSMCs treated with 10 M LOE-908 or 10 M SK&F-96365 before stimulation with ET-1 was similar to that in ICA VSMCs treated with 10 M LOE-908 or 10 M SK&F-96365 after stimulation with ET-1 (ϳ60% for LOE-908 and ϳ80% for SK&F-96365; Fig. 6D ). Moreover, the sustained increase in [Ca 2ϩ ] i was abolished by combined treatment with 10 M SK&F-96365 and 10 M LOE-908 (Fig. 6D) .
Effects of SK&F-96365 or LOE-908 on 10 nM ET-1-induced mitogenesis.
After stimulation with 10 nM ET-1, both the number of viable cells as estimated by the MTT assay and mitogenic activity as estimated by [ 3 H]thymidine incorporation increased with time up to 48 h (data not shown). Therefore, in subsequent experiments the stimulation time was set at 48 h.
ET-1 stimulated mitogenesis in ICA VSMCs in a concentration-dependent manner, with EC 50 values of 0.7 Ϯ 0.2 and 0.8 Ϯ 0.1 nM for the MTT assay and [ 3 H]thymidine incorporation, respectively. Maximal effects, ϳ5-fold increase in the MTT assay and ϳ4.2-fold increase for [ 3 H]thymidine incorporation, were obtained at concentrations Ն10 nM (Fig. 7) .
We next examined the effects of Ca 2ϩ influx through VOCCs on 10 nM ET-1-induced mitogenesis with nifedipine. Nifedipine up to 1 M inhibited only ϳ10% of ET-1-induced mitogenesis (data not shown). Using SK&F-96365 and LOE-908, we then attempted to determine the effects of Ca 2ϩ influx through VICCs on ET-1-induced mitogenesis. In the following experiments, nifedipine was added to the incubation media at a final concentration of 1 M. SK&F-96365 inhibited a 10 nM ET-1-induced mitogenesis in a concentrationdependent manner with IC 50 values of ϳ2.9 Ϯ 0.2 M and ϳ3.0 Ϯ 0.2 M in the MTT and [
3 H]thymidine incorporation assays, respectively. Maximal inhibition was observed at concentrations Ն10 M (Fig. 8) . The extent of maximal inhibition was ϳ80% (Fig. 9) . Similarly, the IC 50 values of LOE-908 for inhibition of 10 nM ET-1-induced mitogenesis were 3.2 Ϯ 0. dine incorporation, respectively, with maximal inhibition being observed at concentrations Ն10 M (Fig.  8) . The extent of maximal inhibition was ϳ60% (Fig.  9) . In contrast, neither SK&F-96365 nor LOE-908 had any effect at concentrations up to 30 M on the number of cells in the absence of ET-1 (Fig. 8) . Notably, 10 nM ET-1-induced mitogenesis was abolished by combined treatment with maximally effective concentrations (10 M) of LOE-908 and SK&F-96365 (Fig. 9) . ] i to nifedipine, involvement of the VOCC in this response is estimated to be minor, within 10% (Fig. 1) . This is in agreement with previous reports that Ca 2ϩ influx through VOCCs has a minor role in ET-1-induced sustained increase in [Ca 2ϩ ] i (16, 21) . Moreover, a recent report demonstrated that the ET A R is negatively coupled to the L-type VOCC and is positively coupled to receptor-operated Ca 2ϩ -permeable channels in rabbit cerebral cortex arterioles (7). Therefore, Ca 2ϩ channels other than the VOCC may play important roles in ET-1-induced sustained increase in [Ca 2ϩ ] i in ICA VSMCs.
The whole cell currents induced by ET-1 are considered to be conducted through NSCCs for the following reasons. 1) Current-voltage relationships were linear, and the reversal potentials were close to 0 mV (Fig.  2B) , indicating that the currents are conducted through either NSCCs or Cl Ϫ channels. 2) Reversal potentials of the ET-1-induced currents were unaffected by changes in Cl Ϫ concentration in the bath solution (see RESULTS) , indicating that the current is carried through NSCCs. Furthermore, these NSCCs are permeable to Ca 2ϩ , because currents can be induced in a bath solution containing only Ca 2ϩ as a movable cation (Fig. 2, C and D) . These data are in agreement with the previous report that ET-1 can activate nifedipine-insensitive noncation channels in VSMCs (2) . The patch-clamp study showed that two types of Ca 2ϩ -permeable NSCCs are activated by ET-1 in ICA VSMCs: one type was sensitive to LOE-908 and resistant to SK&F-96365, whereas the other was sensitive to both drugs (Fig. 3) . From a pharmacological viewpoint, these channels correspond to NSCC-1 and NSCC-2, respectively, as defined in A7r5 cells (11) .
ICA VSMCs are considered to possess SOCCs, because an increase in [Ca 2ϩ ] i as an index of Ca 2ϩ influx through SOCCs could be induced by thapsigargin (Fig.  4) . As reported previously (11), Ca 2ϩ current through SOCCs cannot be monitored under our conditions of whole cell recordings. This is probably because of latent activation of SOCCs under basal conditions, which results from the presence of the Ca 2ϩ chelator EGTA in the pipette solution (to prevent Ca 2ϩ -activated currents). EGTA is reported to deplete the intracellular Ca 2ϩ store and to activate SOCCs (9) . The SOCC thus defined in ICA VSMCs is sensitive to SK&F-96365 and resistant to LOE-908, indicating that the pharmacolog- 
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ical properties of SOCCs in ICA VSMCs are the same as those in A7r5 cells (11) .
Given that the pharmacological properties of these Ca 2ϩ channels have been clarified, we analyzed the involvement of Ca 2ϩ channels in ET-1-induced increase in [Ca 2ϩ ] i in the presence of nifedipine. ] i consisted of Ca 2ϩ influx through NSCC-1 and NSCC-2, the contribution of Ca 2ϩ influx through NSCC-2 was calculated to be 40%. In conclusion, Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCC contributes ϳ20%, 40%, and 40%, respectively, to the increase in [Ca 2ϩ ] i induced by ET-1 in ICA VSMCs (Table 1) . Moreover, the VICCs activated by ET-1 in ICA VSMCs may be pharmacologically similar to those in A7r5 cells (11) . In ICA VSMCs, NSCC-1 is activated by 0.1 nM ET-1, whereas NSCC-2 and SOCC are activated by ET-1 at concentrations Ն1 nM (Figs. 5 and 6 ). Therefore, the sensitivity of NSCC-1 to ET-1 is higher than that of NSCC-2 or SOCC to ET-1. These results indicate that the sensitivity pattern of VICCs to ET-1 in ICA VSMCs may be similar to that in A7r5 cells (11) .
Characterization of Ca 2ϩ channels involved in ET-1-induced mitogenesis in ICA VSMCs. ET-1 induces mitogenic response in ICA VSMCs, judging from results of MTT assay and [ 3 H]thymidine incorporation (Fig. 7) . As demonstrated by sensitivity to BQ-123 and BQ-788, ET-1 mediates increases in mitogenesis through ET A Rs (data not shown).
In light of the nifedipine sensitivity of ET-1-induced mitogenesis, Ca 2ϩ channels other than VOCCs may play important roles in ET-1-induced mitogenesis in ICA VSMCs. Three types of VICCs seem to be involved in ET-1-induced mitogenesis in terms of its sensitivity to LOE-908 and SK&F-96365 (Figs. 8 and 9 ). One type of Ca 2ϩ channel is sensitive to LOE-908 and resistant to SK&F-96365, another type is sensitive to both LOE-908 and SK&F-96365, and the third type is resistant to LOE-908 and sensitive to SK&F-96365. On the basis of pharmacological criteria, these channels are considered to be NSCC-1, NSCC-2, and SOCC, respectively. Moreover, the percent contribution of NSCC-1, NSCC-2, and SOCC to ET-1-induced mitogenesis is calculated to be ϳ20%, 40%, and 40%, respectively (Table 1 ] i response (Fig. 3). 3) Neither SK&F-96365 nor LOE-908 is considered to exert cytotoxic effects on quiescent cells, judging from data from MTT and [ 3 H]thymidine incorporation assays (Fig. 8) .
In conclusion, ET-1 activates VICCs such as NSCC-1, NSCC-2, and SOCC in ICA VSMCs. Notably, Ca 2ϩ influx through these channels plays an essential role in ET-1-induced mitogenesis in ICA VSMCs. We recently showed (17) that the ET-1-induced mitogenic response in Chinese hamster ovary cells expressing recombinant ET A Rs involves a mitogen-activated protein kinase cascade, the activation of which is dependent on both protein kinase C and phosphatidylinositol 3-kinase. However, it is not known whether the same signaling pathways operate in ICA VSMCs. It remains to be determined which signaling pathways are involved in the ET-1-induced mitogenic response and which step(s) of the intracellular signaling pathways requires Ca 2ϩ .
We thank Boehringer Ingelheim (Ingelheim, Germany) for the kind gift of LOE-908.
